Compare YieldMax AMZN Option Income Strategy ETF (AMZY) vs Baxter International Inc (BAX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
YieldMax AMZN Option Income Strategy ETF vs Baxter International Inc — how do they compare? YieldMax AMZN Option Income Strategy ETF trades at $11.26, while Baxter International Inc trades at $27.06 (market cap $14.27B). The key difference: Baxter International Inc pays a 0.14% dividend while YieldMax AMZN Option Income Strategy ETF pays none, and Baxter International Inc is trading nearer its 52-week high, YieldMax AMZN Option Income Strategy ETF nearer its low. Which is the better fit depends on your goals.
| AMZY | BAX | |
|---|---|---|
Sector | Income / Options Overlay | Health |
52-Week High | $15.75 | $28.35 |
52-Week Low | $9.98 | $15.80 |
Market Cap | — | $14.27B |
Enterprise Value | — | $21.79B |
Dividend Yield | — | 0.14% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
AMZY trades at $11.35, down 2.32% today, with a bullish technical signal from moving averages but neutral oscillators. The ETF has paid consistent weekly dividends, with recent distributions ranging from $0.06 to $0.14 per share. Key resistance and support levels are clustered around $12 and $11, respectively, indicating a tight trading range.
Outlook is cautious due to concerns over NAV erosion from its synthetic option strategy, as highlighted by Seeking Alpha. While high yields attract income seekers, the strategy may cap upside and amplify downside risk. Investors should weigh the income benefits against potential long-term underperformance relative to Amazon.
Baxter International Inc. (BAX) trades at $27.78, up 0.83% today, with a bullish technical outlook supported by moving averages. Recent Q2 2026 earnings beat estimates with EPS of $0.56 versus $0.37 expected, and revenue guidance was raised, signaling operational improvement. However, the company posted a net loss of -$957 million in 2025, with negative profit margins and high P/E of 87.85, reflecting valuation concerns amid turnaround efforts.
The stock shows potential from earnings momentum and cost initiatives, but high debt and inconsistent profitability pose risks. Analyst consensus is mixed with a $25.43 price target below current levels, suggesting cautious optimism. Investors should weigh recent beats against structural challenges in the medtech sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About YieldMax AMZN Option Income Strategy ETF
AMZY is an actively managed ETF that seeks to generate monthly income by selling call options on Amazon (AMZN) stock. It aims to provide high yield while maintaining exposure to the price movements of the e-commerce giant.
Read more on AMZY →About Baxter International Inc
Baxter offers a variety of medical instruments and supplies to caregivers. It enhanced its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021. Legacy Baxter offers tools to help patients with acute and chronic kidney failure. It also sells a variety of injectable therapies for use in care settings, such as IV pumps, and administrative sets.
Read more on BAX →
